Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
Clinical trial NCT03107793 · COMPLETED
Trial details
- NCT number
- NCT03107793
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2020-04-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.